November 9–10, 2021
Virtual Conference

Scientific program

Preliminary program – Tuesday, November 9, 2021

9:00–10:30 am

Live Session I

CAR T cells for cancer therapy
Keynote: Rossig, Claudia (Münster University Hospital (UKM), Münster, Germany)

Cell based therapy in hematology
Keynote: Ciceri, Fabio (IRCCS Ospedale San Raffaele, Milan, Italy)

10:30–11:00 am

Break

11:00 am – 12:00 pm

Poster Session I

Poster authors (group 1) are available for live chat.

12:00–12:30 pm

Break

12:30-1:15 pm

Industry Sponsered Session

Supported by Gilead

DLBCL: CAR-T data and clinical experience
Glaß, Bertram (Helios Clinic Berlin-Buch, Berlin, Germany)

CAR-T cell therapy in Germany: Clinical experience and status quo
Vucinic, Vladan (University of Leipzig Medical Center, Leipzig, Germany)

MCL: CAR-T data and clinical experience
Heß, Georg (University Medical Center Mainz, Mainz, Germany)

1:15-1:20 pm

Break

1:20-1:45 pm

Industry Flash Talk

Supported by GlaxoSmithKline

Novel immunotherapeutic approaches in multiple myeloma and solid tumors
Merz, Maximilian (University of Leipzig Medical Center, Leipzig, Germany) and Schmitt, Michael (Heidelberg University Hospital, Heidelberg, Germany)

1:45-2:15 pm

Break

2:15-3:45 pm

Live Session II

Cell based therapy in oncology
Keynote: Abken, Hinrich (RCI – University of Regensburg, Regensburg, Germany)

Cancer vaccines and vector based therapy
Keynote: Cathomen, Tony (Medical Center – University of Freiburg, Freiburg, Germany)

3:45-4:15 pm

Break

4:15-5:15 pm

Poster Session II

Poster authors (group 2) are available for live chat.

 

 

Preliminary program – Wednesday, November 10, 2021

9:00-10:30 am

Live Session III

Cancer immunotherapy by checkpoint inhibition
Keynote: Haanen, John (The Netherlands Cancer Institute, Amsterdam, The Netherlands)

Combining cell therapy and immune checkpoint inhibitors
Keynote: Chabannon, Christian (Institut Paoli-Calmettes, Marseille, France)

10:30-11:00 am

Break

11:00 am - 12:00 pm

Poster Session III

Poster authors (group 3) are available for live chat.

12:00 –12:30 pm

Break

12:30-1:15 pm

Industry Sponsered Session

Supported by Novartis

Pro-Tumor Inflammation (PTI) - a new target for fighting cancer. First findings in NSCLC.
Kobold, Sebastian (University Hospital of Munich (LMU), Munich, Germany)

Immune targeted approaches in myeloid neoplasms and lymphoma
Platzbecker, Uwe (University of Leipzig Medical Center, Leipzig, Germany)

1:15–1:20 pm

Break

1:20–1:45 pm

Industry Flash Talk

Supported by Bristol Myers Squibb

tba

1:45–2:15 pm

Break

2:15–3:45 pm

Live Session IV

Biomarkers and immuno monitoring
Keynote: Dienstmann, Rodrigo (Vall d'Hebron Institute of Oncology, Barcelona, Spain)

Precision medicine addressing tolerance and inflammation
Keynote: Kordasti, Shahram (Kings College London, London, UK)

3:45-4:15 pm

Break

4:15-5:00 pm

Industry Sponsered Session

Supported by Amgen

T cell engaging therapies: Blinatumomab and beyond
Bargou, Ralf C. (University Hospital Würzburg, Würzburg, Germany)